Quality Control During Drug Development

Article

Published: December 8, 2022

Written by

A gloved hand holds a small magnifying glass over white, disc-shaped pills.

Credit: iStock.

Peptide therapeutics offer distinct and tunable pharmacokinetic and pharmacodynamic profiles, and the success of GLP-1 receptor agonists such as Ozempic and Mounjaro is fueling innovation.

But as the complexity and diversity of these therapeutics grow, robust analytical methods are essential to ensure the quality, safety, and efficacy of the final product.

View this article to discover analytical solutions for:

Sensitive methods to determine critical quality attributes
Analytical solutions for every step from impurity assessment to bioanalysis studies
The unique advantages of peptide therapeutics

Sponsored by

Meet the Author

Neeta Ratanghayra, MPharm

Freelance Medical Writer

Neeta Ratanghayra is a freelance medical writer specializing in developing content for the pharma, biotech and healthcare industries. She has a Master’s degree in Pharmacy and has worked on a variety of medical writing deliverables for global pharma companies and healthcare organizations. Before delving into medical writing, Neeta worked in the clinical research industry, where she handled multiple clinical research projects intended for various regulatory submissions.

View this Article for FREE Now!

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.

Experiencing issues viewing the form? Click here to access an alternate version

Drug Discovery

Drug Discovery

Quality Control During Drug Development